Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer version label changes from v3.7.2 to v3.8.0, while the clinical trial record history remains unchanged.SummaryDifference0.1%

- Check23 days agoChange DetectedA sitewide banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.7%

- Check30 days agoChange DetectedThe site footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history now includes a new revision entry (v3.7.0). The previous revision (v3.6.6) is removed from the visible history, updating the page's change log.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page history now shows a new release entry: Revision: v3.6.6, replacing the previous v3.6.5. This indicates a system update to the ClinicalTrials.gov interface rather than changes to trial data.SummaryDifference0.1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.